CAVALIERI, STEFANO
CAVALIERI, STEFANO
Dipartimento di Oncologia ed Emato-Oncologia
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol
2023 S. Cavalieri, C. Vener, M. Leblanc, L. Lopez-Perez, G. Fico, C. Resteghini, D. Monzani, G. Marton, G. Pravettoni, M. Moreira-Soares, D.E. Filippidou, A. Almeida, A. Bilbao, H. Mehanna, S. Singer, S. Thomas, L. Lacerenza, A. Manfuso, C. Copelli, F. Mercalli, A. Frigessi, E. Martinelli, L. Licitra
A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images
2021 S.A. Keek, F.W.R. Wesseling, H.C. Woodruff, J.E. van Timmeren, I.H. Nauta, T.K. Hoffmann, S. Cavalieri, G. Calareso, S. Primakov, R.T.H. Leijenaar, L. Licitra, M. Ravanelli, K. Scheckenbach, T. Poli, D. Lanfranco, M.R. Vergeer, C.R. Leemans, R.H. Brakenhoff, F.J.P. Hoebers, P. Lambin
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia
2021 N.A. Iacovelli, R. Ingargiola, N. Facchinetti, M. Franceschini, D.A. Romanello, P. Bossi, C. Bergamini, S. Alfieri, S. Cavalieri, G. Baron, G. Aldini, L. Locati, E. Orlandi
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial
2021 L.D. Locati, S. Cavalieri, C. Bergamini, C. Resteghini, E. Colombo, G. Calareso, L. Mariani, P. Quattrone, S. Alfieri, P. Bossi, F. Platini, I. Capone, L. Licitra
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
2019 D. Galbiati, S. Cavalieri, S. Alfieri, C. Resteghini, C. Bergamini, E. Orlandi, F. Platini, L. Locati, L. Giacomelli, L. Licitra, P. Bossi
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma
2019 W. van Boxtel, L.D. Locati, A.C.H. van Engen-van Grunsven, C. Bergamini, M.A. Jonker, E. Fiets, S. Cavalieri, S. Tooten, E. Bos, P. Quattrone, C.M.L. van Herpen, G.W. Verhaegh, J.A. Schalken, L. Licitra, C.M.L. van Herpen
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
2021 C. Peraldo-Neia, P. Ostano, M. Mello-Grand, F. Guana, I. Gregnanin, D. Boschi, S. Oliaro-Bosso, A.C. Pippione, A. Carenzo, L. De Cecco, S. Cavalieri, A. Micali, F. Perrone, G. Averono, P. Bagnasacco, R. Dosdegani, L. Masini, M. Krengli, P. Aluffi-Valletti, G. Valente, G. Chiorino
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
2022 S. Cavalieri, M. Serena Serafini, A. Carenzo, S. Canevari, D. Lenoci, F. Pistore, R. Miceli, S. Vecchio, D. Ferrari, C. Moro, A. Sponghini, A. Caldara, M. Cossu Rocca, S. Secondino, G. Moretti, N. Denaro, F. Caponigro, E. Vaccher, G. Rinaldi, F. Ferraù, P. Bossi, L.F.L. Licitra, L. de cecco
An old but still unanswered question in recurrent or metastatic salivary duct carcinoma
2021 S. Cavalieri, L.D. Locati, L. Licitra
Baseline mri-radiomics can predict overall survival in non-endemic ebv-related nasopharyngeal carcinoma patients
2020 M. Bologna, V. Corino, G. Calareso, C. Tenconi, S. Alfieri, N.A. Iacovelli, A. Cavallo, S. Cavalieri, L. Locati, P. Bossi, D.A. Romanello, R. Ingargiola, T. Rancati, E. Pignoli, S. Sdao, M. Pecorilla, N. Facchinetti, A. Trama, L. Licitra, L. Mainardi, E. Orlandi
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials
2022 D. Lenoci, A. Carenzo, S. Cavalieri, F. Pistore, M.S. Serafini, P. Bossi, S. Schmitz, J.-. Machiels, L.F. Licitra, L. De Cecco
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
2021 P. Loap, B. Vischioni, M. Bonora, R. Ingargiola, S. Ronchi, V. Vitolo, A. Barcellini, L. Goanta, L. De Marzi, R. Dendale, R. Pacelli, L. Locati, V. Calugaru, H. Mammar, S. Cavalieri, Y. Kirova, E. Orlandi
Bleeding complications in patients with squamous cell carcinoma of the head and neck
2021 C. Bergamini, R.L. Ferris, J. Xie, G. Mariani, M. Ali, W.C. Holmes, K. Harrington, A. Psyrri, S. Cavalieri, L. Licitra
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: case series and large-scale pharmacovigilance analysis
2021 D.M. Filippini, M. Gatti, V. Di Martino, S. Cavalieri, M. Fusaroli, A. Ardizzoni, E. Raschi, L. Licitra
Clinical implications for pro-GRP in small cell lung cancer. A single center experience
2018 S. Cavalieri, D. Morelli, A. Martinetti, G. Galli, F. Nichetti, F.G.M. DE BRAUD, M. Platania
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
2019 R. Depenni, M. Cossu Rocca, D. Ferrari, G. Azzarello, C. Baldessari, M. Alu, F. Nole, C. Codeca, G. Boscolo, M. Piccininni, S. Cavalieri, P. Bossi
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma
2021 S. Cavalieri, M. Serafini, A. Carenzo, S. Canevari, R. Brakenhoff, C. Leemans, I. Nauta, F. Hoebers, M. van den Hout, K. Scheckenbach, T. Hoffmann, L. De Cecco
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis
2019 G. Galli, S. Cavalieri, L. Di Guardo, C. Cimminiello, F. Nichetti, F. Corti, M. Garcia, B. Pappalardi, C. Fallai, F. de Braud, M. Platania, M. Del Vecchio
Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting : the INT Milan experience
2016 S. Cavalieri, L. Di Guardo, C. Cimminiello, A. Bono, E. Tolomio, A. Colombetti, B. Valeri, G. Di Tolla, F. de Braud, M. Del Vecchio
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report
2022 L.D. Locati, M.S. Serafini, A. Carenzo, S. Canevari, F. Perrone, E. Orlandi, S. Delbue, S. Cavalieri, G. Berzeri, A. Pichiecchio, L.F. Licitra, E. Marchioni, L. De Cecco